C2N Diagnostics Is A Specialty Diagnostics Company Dedicated To Improving Brain Health Through Advanced Biomarker Technologiesfounded By Drsdavid Holtzman And Randall Bateman From Washington University School Of Medicinethe Company Operates A Clia Certified And Cap Accredited Clinical Laboratory In Stlouismissouri C2N Focuses On Enhancing The Early Diagnosis And Treatment Of Alzheimerae S Disease And Related Neurodegenerative Disordersits Flagship Productthe Precivityada C Blood Testaccurately Detects Brain Amyloid Plaques Associated With Alzheimerae Sproviding A Non Invasive Alternative To Traditional Diagnostic Methodsthe Company Also Offers Biomarker Services That Support Clinical Trials By Facilitating Patient Enrollment And Monitoring Treatment Responsesc2N Collaborates With Various Pharmaceutical Companiesacademic Institutionsand Nonprofitscontributing To Over 150 Alzheimerae S Studies Worldwide
